Shandong Baolingbao Biotechnology Company

[ China (Mainland) ]

  • 1st
Business Type:
Manufacturer
Year Established:
1996
Total Revenue:
Main Markets:

Company Description

Shandong Baolingbao Biotechnology Co.,Ltd is a national grade high-tech company, leading as a biology engineering company among other domestic manufacturers of the same trade. Our company has passed the authentication of ISO9001/2000, ISO14001 and HACCP certification system, HALAL and KOSHER certificates. Covering an area of 350,000 square meters, the company has fixed assets of 280 million yuan and 686 employees. Our product focuses on sweeteners, food additives mainly such as Erythritol, Isomaltooligosaccharide, Maltodextrin, Dextrose monohydrate, High fructose corn syrup, L-glutamine etc, which have been exported to Korea, Japan, India, Western Europe, Malaysia and Australia. Total annual output of our products is 250,000 tons, including Isomalto-oligosaccharide of 35,000 tons, Fructo-oligosaccharide of 5,000 tons, Malto-oligosaccharide of 10,000 tons, Erythritol of 3,000 tons, Isomaltitol of 5,000 tons, Polydextrose of 5,000 tons, Indigestible dextrin of 10,000 tons, L-Glutamine of 600 tons, Maltodextrin of 30,000 tons, Dextrose monohydrate of 20,000 tons and High fructose corn syrup of 100,000 tons. We are to actualize three projects (SBU, VIP and DNA), stand out three emphasizes (VIP business, VIP customers and VIP employees), realize three kinds of breakthrough (Internationalization, Communication and Capitalization). We will try our best to have our product famous brand of China, our company pilot enterprise of national level industrial technique center and agriculture industrialization. With occupation of 400 acres and total assets of one billion yuan, Baolingbao Functional Saccharide Science and Technology Industrial Zone is under construction. Domestic and foreign investors are much welcomed to visit and cooperate with us. Based upon equal and mutual business prosperity, we wish to cooperate with worldwide clients and investors concerning trade, economy and technology to develop health-care functional sugar source.